Exclusive

Publication

Byline

Location

US Patent Issued to Baylor College of Medicine on Sept. 8 for "Coronavirus main protease inhibitors and methods using same" (Texas, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,190, issued on Sept. 8, was assigned to Baylor College of Medicine (Houston). "Coronavirus main protease inhibitors and methods using same"... Read More


US Patent Issued to Eisai R&D Management on Sept. 8 for "Production method for synthetic intermediate of monocyclic pyridine derivative" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,191, issued on Sept. 8, was assigned to Eisai R&D Management Co. Ltd. (Tokyo). "Production method for synthetic intermediate of monocyclic ... Read More


US Patent Issued to PHARMABLOCK SCIENCES (NANJING) on Sept. 8 for "CDK9 inhibitor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,192, issued on Sept. 8, was assigned to PHARMABLOCK SCIENCES (NANJING) INC. (Nanjing, China). "CDK9 inhibitor and use thereof" was invented... Read More


US Patent Issued to C4 Therapeutics on Sept. 8 for "Tricyclic ligands for degradation of IKZF2 or IKZF4" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,193, issued on Sept. 8, was assigned to C4 Therapeutics Inc. (Watertown, Mass.). "Tricyclic ligands for degradation of IKZF2 or IKZF4" was ... Read More


US Patent Issued to The Trustees of the University of Pennsylvania, DANA-FARBER CANCER INSTITUTE on Sept. 8 for "Compounds for the treatment of human immunodeficiency virus" (Pennsylvania, Virginia, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,194, issued on Sept. 8, was assigned to The Trustees of the University of Pennsylvania (Philadelphia) and DANA-FARBER CANCER INSTITUTE (Bost... Read More


US Patent Issued to HitGen on Sept. 8 for "Immunomodulator" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,195, issued on Sept. 8, was assigned to HitGen Inc. (Chengdu, China). "Immunomodulator" was invented by Jin Li (Chengdu, China), Dengyou Zh... Read More


US Patent Issued to AstraZeneca on Sept. 8 for "N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides" (Swedish Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,196, issued on Sept. 8, was assigned to AstraZeneca AB (Sodertalje, Sweden). "N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carbox... Read More


US Patent Issued to NATCO PHARMA on Sept. 8 for "Process for the preparation of venetoclax and its polymorphs thereof" (Indian Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,197, issued on Sept. 8, was assigned to NATCO PHARMA Ltd. (Hyderabad, India). "Process for the preparation of venetoclax and its polymorphs... Read More


US Patent Issued to Shanghai Fosun Pharmaceutical Industrial Development on Sept. 8 for "Amide oxazole compound" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,198, issued on Sept. 8, was assigned to Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. (Shanghai). "Amide oxazole compound" ... Read More


US Patent Issued to The Cleveland Clinic Foundation on Sept. 8 for "Citron kinase inhibitors" (Ohio Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,199, issued on Sept. 8, was assigned to The Cleveland Clinic Foundation (Cleveland). "Citron kinase inhibitors" was invented by Shaun R. St... Read More